LOADING
Comparing JPMorgan Chase (JPM) and Pfizer Inc (PFE) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JPM | PFE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $844.2B | $152.4B |
| P/E Ratio | 15.0 | 19.7 |
| Forward P/E | 14.5 | 9.3 |
| PEG Ratio | 1.68 | 13.77 |
| EPS | $20.88 | $1.36 |
| Revenue Growth (YoY) | 12.7% | -1.2% |
| Profit Margin | 33.9% | 12.4% |
| Return on Equity | 16.5% | 8.9% |
| Dividend Yield | 1.88% | 6.30% |
| Beta | 1.04 | 0.39 |
| 52-Week High | $334.16 | $28.75 |
| 52-Week Low | $233.88 | $20.87 |
| Volume | -- | -- |
JPMorgan Chase is the larger company by market capitalization. JPMorgan Chase trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. JPMorgan Chase has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.